GLOBAL BIRD FLU MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Bird Flu Market is estimated to be valued at USD 1.58 Bn in 2025 and is expected to reach USD 2.24 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032. The Bird Flu Market Size is expanding steadily due to investments in vaccine development, heightened survillance, and recurrent outbreaks.    

Key Takeaways

• According to Virus Type, The H5N1 Category is anticipated to account for the largest share of the Bird Flu market in 2025.
• According to Test Type, The PCR Tests Segment is anticipated to hold major share of the Bird Flu market in 2025.
• According to Treatment Type, Vaccines Category is expected to hold the largest share of 47.3% market share for Bird Flu Market in 2025.
• According to Animal Type, Chickens Category is expected to hold the largest share for Bird Flu Market in 2025, due to their enormous numbers and crucial significance in the world’s poultry farming, particularly in Asia and Africa, where the highest levels of chicken production are found.
• According to region, North America holds the largest market share of 46.7% for Bird Flu market growth by 2025.

Market Overview

The globalmbird flu market is steadily expanding due to government initiatives, the economic importance of the poultry sector, and recurrent outbreaks.  With Asia Pacific dominating in both market share and outbreak frequency, vaccines and diagnostics are essential to market expansion.

For instance, in March 2025, As the bird flu continues to impact egg shortages and drive historically high prices, New York City’s bodegas are on the front lines.

Current Events and Its Impact on the Bird Flu Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Pipeline Analysis

The bird flu (avian influenza) market is experiencing robust R&D activity, especially in the development of novel vaccines, antiviral agents, and diagnostic scan tools. The pipeline includes multiple product types such as inactivated, mRNA, and recombinant vaccines, as well as advanced antivirals like neuraminidase inhibitors and adamantanes.

Recent trends show a focus on innovation across administration routes including injectables, inhalation devices, and oral formulations to improve efficacy and patient compliance. Collaborative research, technology transfers, and pilot programs are also prominent, driven by the need for rapid response to outbreaks and evolving viral strains. 

Patent Landscape

The patent landscape in the bird flu market is highly competitive, with leading pharmaceutical and biotech companies securing intellectual property around vaccine formulations, novel delivery systems, and diagnostic technologies. Key players such as Boehringer Ingelheim, Ceva Santé Animale, Zoetis, and Merck & Co. are actively filing patents to protect innovations in both human and animal health segments. The landscape is characterized by a mix of proprietary vaccine strains, adjuvant technologies, and rapid molecular diagnostic platforms, reflecting the market’s emphasis on differentiation and first-mover advantage.

Reimbursement Scenario

• Reimbursement for bird flu treatments and preventive measures varies by region and product type. In developed markets like North America and Europe, government and institutional supply channels play a significant role, especially for vaccines and diagnostics used in pandemic preparedness and livestock protection.
• Public health agencies often subsidize or fully cover vaccination and diagnostic costs to mitigate outbreak risks. In emerging markets, reimbursement is less uniform, with a mix of government programs and out-of-pocket spending, particularly in the poultry sector.
• Recent US tariff policies have also impacted cost structures, prompting manufacturers to adjust sourcing and pricing strategies to maintain affordability and supply reliability.

Prescribers’ Preference

• Prescribers including veterinarians, infectious disease specialists, and primary care providers tend to favor products with proven efficacy, rapid onset of action, and regulatory approval.
• For animal health, vaccines are the primary preventive tool, with prescribers preferring broad-spectrum or recombinant vaccines that offer protection against multiple strains. In human health, antivirals and supportive care are commonly prescribed for confirmed cases, while rapid medical diagnostic kits are widely used for early detection and containment.
• There is a growing inclination towards products that integrate telehealth monitoring and digital reporting, reflecting the increasing role of technology in outbreak management and patient follow-up.

Segmental Insights

To learn more about this report, Download Free Sample

Bird Flu Market Insights, by Treatment Type

In terms of treatment type, the vaccines segment is expected to contribute largest share of the Bird Flu market trends in 2025. The vaccines segment is a critical and rapidly evolving part of the global bird flu (avian influenza) market, driven by recurring outbreaks and the need for effective disease control in poultry and, potentially, humans.

Bird Flu Market Insights, by Virus Type  

In terms of virus type, the H5N1 segment is expected to contribute largest share of the Bird Flu market trends in 2025. The H5N1 segment is a central focus within the global Bird Flu Market due to its significant impact on both animal and human health. H5N1, a highly pathogenic avian influenza (HPAI) subtype, has been responsible for widespread outbreaks in poultry and wild birds, with recent years seeing unprecedented damage to poultry and dairy farms, particularly in the United States and Europe.  

For instance, in July 2024, A new project aiming to accelerate the development and accessibility of human avian influenza (H5N1) messenger RNA (mRNA) vaccine candidates for manufacturers in low- and middle-income countries has been launched today. The Argentinian manufacturer Sinergium Biotech will lead this effort leveraging the World Health Organization (WHO) and the Medicines Patent Pool (MPP) mRNA Technology Transfer Programme.  

Bird Flu Market Insights, by Test Type  

In terms of test type, the PCR tests segment is expected to contribute largest share of the Bird Flu market trends in 2025. PCR (Polymerase Chain Reaction) tests represent a critical segment in the bird flu (avian influenza) diagnostics market. Recognized as the gold standard, PCR testing is highly valued for its ability to detect specific viral genetic material with high sensitivity and specificity, making it essential for accurate diagnosis and surveillance of avian influenza outbreaks.   

Bird Flu Market Insights, by Animal Type

In terms of animal type, the chickens segment is expected to contribute largest share of the Bird Flu market trends in 2025. The chickens segment in the bird flu market is significant due to the high impact of avian influenza outbreaks on chicken populations and related market dynamics.

Chickens are highly susceptible to avian influenza viruses, and outbreaks often lead to large-scale culling to control the spread, which in turn affects supply and prices. For example, an increase of 1 million infected birds in a week can cause a price increase of 14.5% for chickens, reflecting their economic importance in the poultry sector.  

Regional Insights

To learn more about this report, Download Free Sample

North America Bird Flu Market

North America has established itself as the dominant region having a major share of 46.7% in the global bird flu market in 2025. The U.S. is home to several major players that manufacture vaccines and diagnostics for avian influenza. Major poultry markets in the U.S. and Canada have helped North America lead in terms of outbreak preparedness and prevention measures.

Stringent food safety regulations require the widespread adoption of biosecurity systems across commercial poultry farms. Leading pharmaceutical companies in the U.S. have made major R&D investments towards developing universal avian flu vaccines. This allows North America to better tackle novel strains of avian influenza before these spread globally.

Europe Bird Flu Market

Europe's bird flu market is expected to witness growth due to high immunization rates across the region. Several European nations have prioritized vaccine development and distribution over the past decade in response to periodic outbreaks. For example, according to the data published by European Centre for Disease Prevention and Control (ECDC), in 2018, over 200 million doses of H5N1 vaccine were administered across Europe.  

Bird Flu Market In Asia Pacific

Asia Pacific has emerged as the fastest growing regional market for bird flu prevention and control. Countries like China, India, and Vietnam have tremendous poultry production and consumption. This naturally elevates the risks of avian influenza outbreaks stemming from migratory wild birds. Several tropical countries in Southeast Asia also lie along major migratory flyways from Eastern Europe and Central Asia, where outbreaks frequently occur.

While still developing, the biosafety practices are rapidly expanding across small farms and live bird markets. This can potentially limit future spread within these densely populated regions. The industry presence of global vaccine manufacturers has boosted vaccination adoption in many high-risk Asian nations. These players are also actively engaged in monitoring and surveillance programs with governments and veterinary organizations.   

Bird Flu Market Dominating Countries

U.S Bird Flu Market

The United States is a dominant force in the global bird flu market, driven by significant investments in biosecurity, surveillance, and vaccine development. The U.S. government has launched comprehensive strategies, such as the recent $1 billion federal initiative, to curb highly pathogenic avian influenza (HPAI), protect the poultry industry, and stabilize egg prices.   

India Bird Flu Market

India plays a critical role in the bird flu market due to its vast poultry industry and frequent outbreaks linked to high-density farming conditions. The country’s large-scale poultry production makes it susceptible to avian influenza transmission, prompting ongoing investments in surveillance, vaccination programs, and public health interventions.   

Bird Flu Market In China

China stands as one of the most influential countries in the bird flu market, largely due to its status as the world’s largest poultry producer. The country faces ongoing challenges with avian influenza, resulting in robust government-led vaccination campaigns, strict surveillance, and rapid response strategies.

Bird Flu Market: Key Developments

• February 2025, The UNMC College of Public Health has launched a new podcast, “For the Health of It: Guiding Conversations on Community Health,” with its first episode focusing on avian influenza.
• December 2024, The U.S. reported its first severe human case of bird flu on Wednesday in a Louisiana resident who is hospitalized in critical condition after suspected contact with an infected backyard flock.

Market Report Scope

Bird Flu Market: Growth Drivers

• Rising Animal Population Susceptible to Bird Flu: 

With exponential growth in world population over the past few decades, demand for animal protein in the form of poultry, pork and other meats has also increased substantially across both developed and developing regions of the world. As a result, livestock and poultry farming has grown aggressively with many countries, ramping up production to cater to the strong demand for meat both locally as well as for export.

Rising animal populations have made these animals, especially chicken and ducks, more susceptible and vulnerable to various viral infections and diseases. Bird flu virus, being a highly contagious disease among avian species, has found an expanded host in the hugely inflated animal populations worldwide. Additionally, many countries still follow unsanitary practices in their live animal markets which brings several bird species in close contact with each other as well as humans, thereby increasing the risk of bird flu virus transmission.

• Surveillance & Monitoring of Migratory Wild Birds: 

Not only domestic poultry, migratory wild birds like ducks, geese and shorebirds are also known to play a role in the natural ecology of avian influenza viruses. These act as the natural host and reservoir for these viruses, with no apparent illness. During seasonal migrations, wild birds can travel thousands of miles potentially spreading viruses over long distances. Proper surveillance and monitoring of migratory patterns and avian influenza infections in wild bird populations is essential for understanding the avian influenza's epidemiology and assessing the risk of transmission.

Governments and international organizations have stepped up efforts to track the migrations routes of wild birds and monitor the prevalence of avian influenza in these species. It also aids in identifying sources of novel virus introductions and implementing timely control response. The information gained from wild bird surveillance assists in risk assessment and disease management strategies. It is anticipated that with growing emphasis on such monitoring activities globally, the demand for relevant diagnostic tests, sampling kits and data management solutions in the bird flu market will continue to sustain.

• Research funding for treatment of bird flu: 

Research funding for the treatment of avian influenza, commonly known as bird flu, has significantly contributed to the growth of the bird flu market in recent years. Several government and international health organizations have increased research grants and funding to develop effective vaccines and antiviral drugs against the different strains of the H5N1 and H7N9 viruses.

For instance, on December 12, 2023, The Coalition for Epidemic Preparedness Innovations (CEPI) collaborated with Chungbuk National University (CBNU) in South Korea to further accelerate the development of CBNU's self-amplifying mRNA vaccine technology. CBNU will first test the platform against the avian influenza H5N1 virus with the help of CEPI. The findings will serve as a model for evaluating this new technology and investigating how it may be used to respond to a future Disease X in as little as 100 days.

Hence, the increased research support is expected to accelerate the product development pipeline in the coming years. As effective prevention and treatment options become available, it is likely to boost demand for relevant products.

Market Trends

• Increasing popularity of backyard poultry: 

The rising popularity of backyard poultry keeping in residential areas across many countries has started influencing the bird flu market in notable ways. With more amateur chicken, duck, and other bird owners raising small flocks in and around cities, there is a greater risk of various avian influenza viruses spreading more easily between domestic and wild birds. Backyard flocks tend to be raised in smaller enclosures or free-range setups with less robust biosecurity practices as compared to commercial poultry farms.

This makes it harder to isolate infected birds and prevent diseases from jumping between backyard and commercial operations or migratory wild birds. When H5N1 avian influenza, commonly known as bird flu, enters a backyard setup, the chances of it spreading to other backyard flocks or larger commercial facilities is higher due to the integration of smaller flocks in suburban landscapes.

• Advancement in vaccine technology: 

Advancement in vaccine technology is having a significant impact on the bird flu market. Scientists and researchers have been working tirelessly over the past few years to develop more effective vaccines against various bird flu strains such as H5N1 and H7N9. Several countries have reported breakthroughs in developing universal flu vaccines that offer cross-protection against multiple subtypes of influenza virus in poultry.

For instance, in December 2022, Ministry of Agriculture & Farmers Welfare, India, developed an inactivated low pathogenic avian influenza (H9N2) vaccine for chickens by using new technology. The vaccine will contribute significantly to increase in income of poultry farmers by reducing the economic loss due to the disease. This universal vaccine provides broader and longer lasting immunity to birds as compared to traditional vaccines and requires fewer doses. Consequently, it is more cost effective for poultry farmers and governments to vaccinate large flocks.

• Increasing demand for rapid diagnostic tests: 

Increasing demand for rapid diagnostic tests is a key trend that is positively influencing the bird flu market. With the growing risk of bird flu outbreaks across various geographies, there is heightened awareness among various stakeholders such as governments, farmers, veterinarians, and others about the need for swift diagnosis and containment.

Rapid diagnostic tests play a crucial role in this regard by enabling early detection of the avian influenza virus. This helps to stop the spread before it can develop into a large outbreak. Various countries and international organizations are now focusing on building local surveillance and rapid response capabilities to deal with any emergencies. In addition, growing private sector interest is also supplementing demand.

Commercial poultry farms and egg producers are incorporating point-of-care testing as part of biosecurity protocols to minimize business disruptions from outbreaks. Some state governments in the U.S. have made it mandatory for commercial holdings to screen birds regularly using rapid tests.

Bird Flu Market: Opportunities

• Development of low-cost vaccines: 

The development of low-cost vaccines could unlock tremendous potential in the bird flu market. As outbreaks of avian influenza continue to threaten poultry farms and public health across the globe, affordable and accessible vaccination programs are critical to mitigate risks. Currently, vaccination is not widely utilized as a control method due to the high costs associated with developing and administering traditional flu shots.

However, recent scientific advances have shown promise for more affordable alternatives. Researchers are working on new delivery methods such as nasal sprays or food additives that could be mass-produced and distributed more efficiently. Cheap and easy-to-administer vaccines would make it financially viable for commercial farms and backyard flocks in developing nations to implement vaccination protocols as part of their routine healthcare activities. This could significantly curtail outbreaks and save lives.

• Genetic Engineering Research for Resistant Breeds: 

Genetic engineering research for developing bird flu resistant poultry breeds presents a great opportunity for the bird flu market to grow sustainably over the long term. Scientists have been conducting extensive research to genetically modify poultry breeds that are resistant to different strains of avian influenza. This research aims to reduce the susceptibility of commercial poultry like chickens and ducks to bird flu viruses. This would bring much needed stability to the poultry farming industry as well as security of supply to poultry consumers.

Rather than reacting to outbreaks by destroying livestock, scientists are working to develop a long-term solution through targeted genetic edits that allow birds to coexist safely with these viruses. Several research institutes and universities around the world are engaged in projects exploring new gene editing techniques like CRISPR to understand the genetic basis of bird flu susceptibility.

• Growth in consumption of poultry meat and eggs: 

The consumption of poultry meat and eggs is growing steadily around the world as a more affordable and nutritious protein sources. According to data from the UN Food and Agriculture Organization, in 2021, global consumption of meat proteins is projected to increase by 14% by 2030 as compared to the base period average of 2018-2020, driven largely by income and population growth.

Protein availability from beef, pork, poultry, and sheep meat is projected to grow 5.9%, 13.1%, 17.8% and 15.7% respectively by 2030. This rise in demand is expected to continue due to population growth, increasing incomes in developing nations, and preferences among health-conscious consumers in developed markets.

As poultry consumption grows, the need for effective prevention and control of bird flu outbreaks will become more pressing to safeguard food security and public health. Greater consumption means a larger supply is needed to meet demand, which increases risks if any outbreak occurs due to the concentration and movement of more birds.

Analyst Opinion

• Global bird flu market is witnessing steady growth due to increasing outbreaks globally. Asia Pacific currently dominates the market, owing to growing poultry farming primarily in China and Southeast Asian countries. These nations account for over half of the world's poultry production.
• As the risk of transmission from birds to humans remains high in overcrowded farming conditions, countries in the region can boost surveillance and vaccination programs. This boosts demand for diagnostic tests, personal protective equipment, and vaccines in the near term.
• North America and Europe are also important markets driven by strong R&D focus on developing novel therapies and preventive solutions for high pathogenic strains.
• However, regulatory approvals for new products tend to be lengthy, thus, posing a moderate restraint. Lower prevalence compared to Asia moderately limits growth opportunities in developed nations.    

Bird Flu Market: Key Companies

Some of the key players in the global Bird Flu market are Boehringer Ingelheim, Ceva Santé Animale, Zoetis, Merck & Co., Ringpu Biology, Yebio Bioengineering, FATRO, CAVAC, ChengDu Tecbond, QYH Biotech, Elanco, Phibro Animal Health, Vetoquinol, Hipra, Venkys, Anicon Labor GmbH, Medion Farma Jaya, Bioveta, Lohmann Animal Health and Biogenesis Bago.  

Sources

Primary Research interviews:

• Veterinary virologists
• Epidemiologists specializing in zoonotic diseases
• Poultry farmers and cooperative heads
• Vaccine manufacturing heads (biotech/pharma)
• Animal husbandry department officials
• Public health officials
• Poultry supply chain managers

Databases:

• Scopus
• EMBASE
• Global Health (CABI)
• AGRICOLA
• CAB Abstracts
• Food and Agriculture Organization (FAO) Statistics

Magazines:

• Poultry World
• World Poultry
• Feed Strategy
• Poultry International
• Veterinary Practice
• The Poultry Site

Journals:

• Avian Diseases
• Journal of Virology
• Emerging Infectious Diseases
• Journal of Wildlife Diseases
• Veterinary Microbiology
• Vaccine
• Transboundary and Emerging Diseases
• Journal of Animal Science

Newspapers:

• The New York Times (Health/Science section)
• The Guardian (Environment and Health sections)
• The Hindu (Science & Tech, National pages)
• The Times of India (Agriculture and Health pages)
• The Washington Post (Health and Environment)
• The Japan Times (for Asia-Pacific outbreaks)

Associations:

• World Organization for Animal Health (WOAH)
• Food and Agriculture Organization (FAO)
• International Poultry Council
• American Association of Avian Pathologists
• All India Poultry Development and Services Pvt Ltd
• Poultry Federation of India
• European Food Safety Authority
• U.S. Poultry & Egg Association

• Proprietary Elements:

CMI Data Analytics Tool, Proprietary CMI Existing Repository of information for last 8 years

*Definition: Bird flu, also known as avian influenza, is a type of influenza virus that primarily affects birds, but can infect various species of animals, including humans. This virus is similar to the human influenza viruses that can cause seasonal flu epidemics, but bird flu is often more virulent in birds. There are several different strains of avian influenza viruses, which are categorized as either low pathogenic (LPAI) or highly pathogenic (HPAI) based on the severity of the illness these cause in birds. The low-pathogenic strains typically cause mild symptoms and may go undetected, while the high-pathogenic strains can lead to severe disease and high mortality rates among bird populations. The most well-known strain of bird flu is the H5N1 subtype of the influenza A virus.